Facebook Twitter LinkedIn Google Plus RSS

Pacira Pharmaceuticals announces proposed public offering of stock

By ,

Parsippany-based Pacira Pharmaceuticals Inc. announced Tuesday that it is offering $100 million of its common stock in a proposed public offering.

According to the release, Pacira plans to grant underwriters 30 days to purchase up to $15 million of additional shares.

Jeffries LLC, Barclays Capital Inc. and BofA Merrill Lynch are acting as the joint bookrunning managers and underwriters for the offering.

ALSO ON NJBIZ:

Green developer Jonathan F. P. Rose preaches sustainability with South Orange site

NJBIZ names the 2014 General Counsel of the Year finalists

Small business owners: Stronger NJ grant process not working

More From This Industry

Emily Bader

Emily Bader


Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com.

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close